As of May 12, 2025, the Hims & Hers Health stock's P/E ratio is 74.61. This results from the current EPS of $0.74 and stock price of $55.21. The PE ratio has decreased by 20% from the past four quarters average of 93.3.
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 41.69 | N/A | $24.18 | $0.58 |
2023 | N/A | N/A | $8.9 | -$0.11 |
2022 | N/A | N/A | $6.41 | -$0.32 |
2021 | N/A | N/A | $6.55 | -$0.58 |
2020 | N/A | N/A | $14.6 | -$0.51 |
2019 | N/A | N/A | $9.9 | -$2.07 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 39.93 | -4.22% | $29.55 | $0.74 |
Dec 2024 | 41.69 | 6.38% | $24.18 | $0.58 |
Sep 2024 | 39.19 | -84.47% | $18.42 | $0.47 |
Jun 2024 | 252.38 | N/A | $20.19 | $0.08 |
Mar 2024 | N/A | N/A | $15.47 | -$0.01 |
Dec 2023 | N/A | N/A | $8.9 | -$0.11 |
Sep 2023 | N/A | N/A | $6.29 | -$0.17 |
Jun 2023 | N/A | N/A | $9.4 | -$0.22 |
Mar 2023 | N/A | N/A | $9.92 | -$0.29 |
Dec 2022 | N/A | N/A | $6.41 | -$0.32 |
Sep 2022 | N/A | N/A | $5.58 | -$0.43 |
Jun 2022 | N/A | N/A | $4.53 | -$0.42 |
Mar 2022 | N/A | N/A | $5.33 | -$0.37 |
Dec 2021 | N/A | N/A | $6.55 | -$0.58 |
Sep 2021 | N/A | N/A | $7.54 | -$0.62 |
HIMS's PE ratio is above its peer stocks NBIX and NVAX.
Stock name | PE ratio | Market cap |
---|---|---|
NVAX Novavax Inc | 2.09 | $1.03B |
NBIX Neurocrine Biosciences Inc | 39.75 | $11.92B |
HIMS Hims & Hers Health Inc | 74.61 | $12.36B |
NVCR NovoCure Ltd | N/A | $2.07B |
The price to earnings ratio for HIMS stock as of May 12, 2025, stands at 74.61.
HIMS's stock price is trading at a higher multiple of earnings, which is why its PE ratio of 74.61 is considered high.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (May 12, 2025), Hims & Hers Health's stock price is $55.21. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.74. Therefore, Hims & Hers Health's price to earnings ratio for today is 74.61. PE RATIO(74.61) = STOCK PRICE($55.21) / TTM EPS($0.74)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.